Search research articles
Contact Us
Filters
Showing results (1-10 of 141) with videos related to
Page
of 15
Sort By:
Annales De Pathologie
|
June 1, 1999
[Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?]
F Penault-Llorca, J Jacquemier
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
F Penault-Llorca, G Viale
Bulletin Du Cancer
|
December 18, 2010
[Adjuvant breast cancer: which clinical and pathological characteristics in 2007?]
F Penault-Llorca, L Arnould
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 16, 2006
[Micrometastatic disease and residual axillary disease. Breast cancer as an example Alct]
F Penault-Llorca, F Mishellany
Bulletin Du Cancer
|
December 8, 2010
[HER2 and gastric cancer: a novel therapeutic target for trastuzumab]
O Bouché, F Penault-Llorca
Bulletin Du Cancer
|
October 2, 2001
[Molecular abnormalities in epithelial ovarian tumors: present and future]
C Vaurs-Barrière, F Penault-Llorca
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 18, 2003
[Principal therapeutic uses of monoclonal antibodies in oncology]
F Penault-Llorca, A Etessami, J Bourhis
Contraception, Fertilite, Sexualite (1992)
|
December 29, 1998
[Natural history of ovarian adenocarcinomas: from epidemiology to experimentation]
T C Hamilton, F Penault-Llorca, J Dauplat
ESMO Open
|
September 6, 2021
Refining patient selection for breast cancer immunotherapy: beyond PD-L1
M Kossai, N Radosevic-Robin, F Penault-Llorca
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 1, 2008
[The use of breast cancer subtype classification to predict local and distant recurrence. A review]
Y Belkacémi, F Penault-Llorca, J Gligorov, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 141) with videos related to
Sort By:
Page
of 15
Annales De Pathologie
|
June 1, 1999
[Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?]
F Penault-Llorca, J Jacquemier
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
F Penault-Llorca, G Viale
Bulletin Du Cancer
|
December 18, 2010
[Adjuvant breast cancer: which clinical and pathological characteristics in 2007?]
F Penault-Llorca, L Arnould
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 16, 2006
[Micrometastatic disease and residual axillary disease. Breast cancer as an example Alct]
F Penault-Llorca, F Mishellany
Bulletin Du Cancer
|
December 8, 2010
[HER2 and gastric cancer: a novel therapeutic target for trastuzumab]
O Bouché, F Penault-Llorca
Bulletin Du Cancer
|
October 2, 2001
[Molecular abnormalities in epithelial ovarian tumors: present and future]
C Vaurs-Barrière, F Penault-Llorca
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 18, 2003
[Principal therapeutic uses of monoclonal antibodies in oncology]
F Penault-Llorca, A Etessami, J Bourhis
Contraception, Fertilite, Sexualite (1992)
|
December 29, 1998
[Natural history of ovarian adenocarcinomas: from epidemiology to experimentation]
T C Hamilton, F Penault-Llorca, J Dauplat
ESMO Open
|
September 6, 2021
Refining patient selection for breast cancer immunotherapy: beyond PD-L1
M Kossai, N Radosevic-Robin, F Penault-Llorca
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 1, 2008
[The use of breast cancer subtype classification to predict local and distant recurrence. A review]
Y Belkacémi, F Penault-Llorca, J Gligorov, et al.
Page
of 15